聪耳通窍汤联合耳针对老年神经性耳鸣近远期疗效观察

目的探讨聪耳通窍汤联合耳针治疗老年神经性耳鸣患者的近远期疗效。方法选取耳鼻喉科门诊收治的老年神经性耳鸣患者136例,按随机数字表法分组,对照组68例予以耳针治疗,研究组68例在对照组基础上予以聪耳通窍汤治疗。检测比较两组间近、远期临床疗效、甲襞微循环指标、血液流变学指标以及不良反应发生率。结果治疗后,对照组总有效率为67.64%(46/68)低于研究组总有效率83.82%(57/68),具有统计学意义(P<0.05);随访6个月后,对照组总有效率64.71%(44/68)低于研究组总有效率89.71%(61/68),具有统计学意义(P<0.05);与对照组比较,研究组治疗后甲襞微循环襻周积分、管襻积分、流态积分及总积分较低,治疗后血浆黏度、高切全血黏度、低切全血黏度及红细胞压积较低,差异具有统计学意义(P<0.05);治疗中出现的不良反应为恶心、腹胀、针刺部位疼痛,两组间不良反应发生率无统计学差异(P>0.05)。结论聪耳通窍汤联合耳针治疗老年神经性耳鸣患者的近远期疗效均较好,能明显改善患者微循环状态及血液流变学指标,减轻内耳循环障碍,具有较高安全性。     

Deep Brain Stimulation——A new treatment for tinnitus

Intractable tinnitus can lead to serious consequences. Study evidence indicates that the central nervous system is involved in generation and maintenance of chronic tinnitus and that tinnitus and other neurologic symptoms such as chronic pain may share similar mechanisms. Brain ablation and stimulation are used to treat chronic pain with success. Recent studies showed that ablation and stimulation in non-auditory areas resulted in tinnitus improvement. Deep brain stimulation (DBS) may be an alternative treatment for intractable tinnitus and deserves further study.     

京剧器乐的听力损伤（附55例调查报告）

本文对从事京剧打击乐的55人（110耳）进行了听力调查及动态观察。利用图表进行对比分析，发现110耳中高频听力损伤89耳，占81％；语频听力损伤32耳，占29.1%；其中伴有高频耳鸣78耳，占70．9％。动态观察30人（60耳），均为永久性听阈阈移。高频听力损伤最早出现的频率是4kHz，并见典型“V”谷，符合噪声性聋的诊断。     

肌源性耳鸣的声导抗测试特征（附3例报告）

本文报道了１１例病例,并以３例典型病例就肌源性耳鸣的声导抗测试的基本方法和特征作了探讨。腭肌阵挛的幅度较大,在鼓室导抗图和声反射曲线上均可出现锯齿状波。镫骨肌阵挛在表情肌运动时可诱发,为持续性,镫骨肌声反射对其无影响或可掩盖之。鼓膜张肌阵挛与面部三叉神经受刺激有关,易疲劳,表现为一短暂的声顺变化波形。     

Otological trauma resulting from the Soho Nail Bomb in London,April 1999

Otological trauma resulting from the Soho Nail Bomb in London, April 1999 We report the otological effects of the April 1999 Soho Nail Bomb on 17 patients. Twenty‐one (62%) tympanic membranes were perforated (pars tensa only); 78% closed spontaneously within 6 months. The mean size of the perforation in the tympanic membrane nearer to the blast was significantly larger than the opposite side [33% ± 8.3 (mean ± SD) and 13% ± 4.1 respectively; P = 0.02]. All patients reported hearing losses that were mixed conductive and sensorineural but mainly high‐frequency sensorineural (4, 6 and 8 kHz, pure tone average 42.3 dB ± 20.5). The sensorineural hearing loss correlated inversely with the distance from the explosion but not with the size of perforation. There was no significant difference in the hearing loss between the ear facing the blast and the opposite ear. Fifteen patients (88%) had temporary tinnitus. No patient complained of any vestibular symptoms. The otological effects of a nail bomb in an enclosed space have not been previously reported. Furthermore, an inverse correlation between hearing loss and distance from the explosion and a significant difference in perforation size facing the blast, compared with the opposite side, are also presented for the first time. The high spontaneous closure rate of perforations and minimal ongoing disability from sensorineural losses favour conservative management in most cases.     

超选择动脉栓塞治疗血管搏动性耳鸣（附2例报告）

采用数字减影血管造影技术超选择性动脉栓塞治愈２例血管搏动怀耳鸣，并就发病原因、机理、治疗措施、临床特征进行讨论。     

利多卡因穴位注射治疗耳鸣的疗效观察

目的观察利多卡因穴位注射治疗耳鸣的疗法。方法应用2%利多卡因穴位注射(穴注组)的方法治疗主观性耳鸣50例,并以50例用扩血管等药物口服做对照(对照组)。结果穴注组有效率为86%,对照组有效率为44%,穴注组疗效明显优于对照组(P<0!01),除一过性面部麻木及少数病人出现短暂的面瘫及眩晕外,未发现其他副作用。结论该方法是治疗主观性耳鸣安全有效的方法。     

12例颈静脉源性耳鸣诊治分析

目的:探讨颈静脉源性耳鸣的诊断及治疗。方法:回顾性分析12例诊断为颈静脉源性耳鸣患者的临床表现、诊断依据及治疗方案,对接受颈内静脉结扎术后患者的近期和远期临床效果进行评价,并对相关文献作一综述。结果:术后1周内,7例诉耳鸣明显减轻或消失,5例无明显改善。远期随访到5例近期明显减轻的患者,其中3例耳鸣无改善,2例耳鸣明显减轻(2/7);远期随访到2例近期耳鸣无明显改善者,其中1例耳鸣无改善,另1例加重,发展为啸鸣音。远期随访时间为术后1～5年。随访到的7例均无明显并发症。结论:颈静脉源性脉动性耳鸣为一排除性诊断,并无金标准,单纯依据脉动性耳鸣病史,按压颈内静脉耳鸣明显减轻或消失,以及耳部CT和颅脑MRI排除相关占位性病变并不足以诊断,联合CT动脉及静脉检查有助于排除硬脑膜动静脉瘘、乙状窦憩室等病变。通过颈内静脉结扎术治疗颈静脉源性耳鸣仍存争议。     

全参数生物反馈指标在主观性耳鸣患者中的应用

目的研究全参数生物反馈在治疗主观性耳鸣患者中的效果。方法对20例主观性耳鸣患者行全参数生物反馈治疗10次,观察治疗前后耳鸣残疾评估量表（Tinnitus Handicap Inventory,THI）得分及全参数生物反馈指标的变化。结果耳鸣患者治疗前后THI总分分别为44．9±22．3和28．0±14．8,差异达到极显著性水平（P〈0．01）;冶疗前后生物反馈指标肌电分别为6．7±1．6和5．1±1．2,差异达到显著性水平（P〈0．05）、治疗前后仪波分别为13．3±6．4和16．4±6．2,差异极显著（P〈0．01）、治疗前后SMR波分别为5．4±1．6和6．2±2．2,差异显著（P〈0．05）。结论主观性耳鸣患者进行生物反馈治疗有效,可明显降低THI总分,改善耳鸣症状,随着耳鸣患者症状减轻,其对应生物反馈指标也发生相应改变。